TOKYO —

Memory lapses, the thinning of skin, and a gradual decrease in bone density are commonly accepted hallmarks of aging. However, groundbreaking research in mice suggests these seemingly disparate consequences of growing older may be interconnected, influenced by the declining levels of a crucial protein deep within the brain. This protein, known as Menin, has demonstrated a remarkable capacity to ameliorate several age-related symptoms when its levels are restored, while a separate intervention with the amino acid D-serine has shown promise in improving cognitive function. These findings, published in the open-access journal PLOS Biology on March 16, 2023, by a team led by Lige Leng of Xiamen University, illuminate a potential nexus between brain inflammation, metabolic regulation, and systemic aging. Subsequent research has further refined this understanding, underscoring the complexities and nuances of translating these laboratory discoveries into human applications.

Unraveling the Hypothalamus and Menin’s Role in Aging

The focal point of this investigation is the hypothalamus, a small but vital region of the brain responsible for orchestrating a multitude of essential bodily functions, including metabolism, appetite, sleep-wake cycles, and body temperature. Crucially, the hypothalamus also appears to play a significant role in the aging process. As inflammatory signaling within this brain region escalates with age, it can precipitate a cascade of detrimental changes, not only within the brain itself but also impacting tissues and organs throughout the body.

Prior to the 2023 study, Leng and his colleagues had established that Menin acts as a key inhibitor of inflammation within the hypothalamus. This discovery naturally led to a pivotal question: could a reduction in Menin’s protective influence be a significant driver of age-related decline? To address this, the research team delved into the precise cellular mechanisms at play.

Their experiments revealed that Menin levels demonstrably decreased with age in specific types of neurons within the ventromedial hypothalamus (VMH), a subregion critically involved in metabolic control. Importantly, this decline was not observed uniformly across all brain cells. Astrocytes and microglia, the brain’s support and immune cells, did not exhibit the same age-related reduction in Menin. This observation suggested a targeted loss of Menin in particular neuronal populations, rather than a generalized decline across the hypothalamic area.

Experimental Evidence: Menin Depletion and Accelerated Aging

To rigorously test the hypothesis that Menin deficiency actively contributes to aging, the researchers employed a sophisticated genetic engineering technique. They developed conditional knockout mice, animals genetically modified to allow for the selective removal of Menin. In younger mice where Menin was experimentally reduced, the study observed a marked increase in hypothalamic inflammation. This heightened inflammation was accompanied by the premature onset of several age-related phenotypes, including a significant reduction in bone mass, thinning of the skin, a noticeable decline in cognitive abilities, and a modestly shortened lifespan. These findings provided compelling evidence that Menin’s presence is not merely correlated with youth but actively defends against the aging process.

The D-Serine Connection: A Neurochemical Link to Cognition

Beyond its role in modulating inflammation, the depletion of Menin was also found to disrupt a critical chemical pathway essential for communication between brain cells. Mice with reduced Menin levels exhibited lower concentrations of D-serine, an amino acid that plays a vital role in activating N-methyl-D-aspartate (NMDA) receptors. These receptors are fundamental to synaptic plasticity, the process by which the strength of connections between neurons is adjusted, a cornerstone of learning and memory formation.

The research identified that an enzyme responsible for D-serine production, itself regulated by Menin, became less active as Menin levels dropped. This reduced enzymatic activity led to a diminished supply of D-serine, thereby impairing the brain’s capacity for robust neural communication. The findings suggested a dual mechanism through which Menin influences cognition: not only by curbing inflammation but also by maintaining the precise neurochemical environment necessary for optimal brain signaling.

It is crucial to distinguish between dietary serine and supplemental D-serine. Serine is naturally present in foods such as soybeans, eggs, fish, and nuts, primarily in its L-serine form, which is incorporated into proteins. While the body can convert L-serine to D-serine, these two forms are not interchangeable, and the consumption of serine-rich foods does not equate to the targeted administration of experimental D-serine. This distinction is vital for the accurate interpretation of potential therapeutic interventions.

Restoring Menin: Reversing Age-Related Deficits in Older Mice

Emboldened by the results of Menin depletion, the research team proceeded to investigate whether augmenting Menin levels in elderly mice could reverse established signs of aging. They employed a gene delivery system to introduce the Menin gene into the hypothalami of 20-month-old mice, a stage considered equivalent to advanced age in humans. This allowed the cells within this region to increase their production of the crucial protein.

The outcomes observed 30 days after the intervention were striking. The treated mice demonstrated significant improvements in skin thickness and bone mass, indicative of a reversal in physical aging markers. Furthermore, they exhibited enhanced performance on a battery of tests assessing learning, general cognition, and balance. These physical and cognitive enhancements were correlated with elevated D-serine levels in the hippocampus, a brain region indispensable for memory consolidation. Perhaps most notably, the study reported that restoring Menin levels in these aged mice also extended their lifespan.

In a parallel experiment, a simpler intervention was tested: administering D-serine directly to mice in their drinking water for three weeks. This approach successfully improved cognitive performance, even in older animals. However, it did not replicate the broader improvements in physical aging traits observed after Menin restoration. This critical distinction highlights that while D-serine may offer cognitive benefits, it does not appear to reverse systemic aging throughout the body in the same comprehensive manner as Menin.

At the time of the study’s publication, Dr. Lige Leng articulated the potential significance of these findings: "We speculate that the decline of Menin expression in the hypothalamus with age may be one of the driving factors of aging, and Menin may be the key protein connecting the genetic, inflammatory, and metabolic factors of aging. D-serine is a potentially promising therapeutic for cognitive decline." He further elaborated, "Ventromedial hypothalamus (VMH) Menin signaling diminished in aged mice, which contributes to systemic aging phenotypes and cognitive deficits. The effects of Menin on aging are mediated by neuroinflammatory changes and metabolic pathway signaling, accompanied by serine deficiency in VMH, while restoration of Menin in VMH reversed aging-related phenotypes."

The Evolving Landscape: Subsequent Research and Broader Context

Since the initial publication, a growing body of research has continued to explore the intricate mechanisms underlying aging, with some studies touching upon pathways related to Menin and hypothalamic function. While these subsequent investigations do not constitute direct validation of the entire Menin-centric aging pathway, they offer valuable context and support for the broader concepts explored.

For instance, a March 2024 study published in the Journal of Physiology and Biochemistry examined Menin’s role in cultured mouse hippocampal cells subjected to stress from the hormone corticosterone. This research found that a compound called itaconate could increase Menin levels, thereby reducing inflammation and a specific form of cell death. When Menin expression was experimentally silenced, this protective effect was abrogated. While this study reinforces Menin’s protective function in a cellular model, it remains a laboratory observation and not a demonstration of slowed aging in living organisms.

Further strengthening the link between hypothalamic signaling and systemic aging, a 2024 study in Cell Metabolism by researchers at Washington University School of Medicine identified a distinct population of hypothalamic neurons that communicate directly with adipose tissue. Interventions aimed at maintaining or stimulating this neural circuit led to increased physical activity and extended lifespan in mice. Although this study involved a different molecular pathway than Menin, it underscored the overarching principle that signals originating from the brain can profoundly influence the aging process beyond the central nervous system.

A comprehensive analysis published in Nature in January 2025 by a team at the Allen Institute provided a broad perspective on age-related cellular changes. By examining approximately 1.2 million mouse brain cells, they pinpointed certain cell types most vulnerable to aging in close proximity to the hypothalamus’s third ventricle. These sensitive cells exhibited reduced activity in genes associated with neuronal function and increased activity in genes linked to immune responses. While this study mapped age-related cellular alterations rather than testing therapeutic interventions, it underscored the hypothalamus as a critical area for future aging research.

Nuances of D-Serine: Not a Universal Anti-Aging Panacea

Conversely, more recent research has introduced a layer of complexity to the idea that simply increasing D-serine levels is universally beneficial for an aging brain.

A study published in Cellular and Molecular Life Sciences in April 2025 investigated mice engineered to exhibit characteristics of Alzheimer’s disease. In this specific disease model, an early surge in D-serine levels coincided with disruptions in brain signaling. Intriguingly, genetically removing the enzyme responsible for D-serine production effectively prevented or mitigated several subsequent cognitive deficits. Although this study focused on a distinct pathological context—Alzheimer’s disease—it powerfully demonstrated that D-serine can exert differential effects depending on the underlying biological processes and disease state.

Further complicating the picture, research published on September 16, 2026, in the Journal of Alzheimer’s Disease explored a different Alzheimer’s mouse model. In this instance, a diet enriched with L-serine led to increased blood levels of both L-serine and D-serine. This dietary intervention partially restored measures of new neuron production in the hippocampus but did not impact the accumulation of amyloid plaques, a hallmark protein associated with Alzheimer’s disease. Crucially, this experiment focused on L-serine supplementation and its effect on neurogenesis, not on direct D-serine supplementation as a broad anti-aging treatment for humans.

Collectively, these later findings suggest that while serine metabolism represents a promising area for scientific inquiry, it is not a straightforward case of "more is always better." The specific form of serine administered, the particular health condition under investigation, and the precise outcome being measured are all critical factors that influence the observed effects. Neither of these more recent studies directly confirms or refutes the original Menin findings but rather adds layers of nuance to the broader conversation around serine and brain health.

Implications for Human Health: A Promising Avenue, Not a Proven Cure

While human research on D-serine exists, it has not yet established it as a definitive treatment for aging. A small, randomized study conducted in 2016, preceding the Menin research, administered a single dose of D-serine to 50 healthy older adults. Participants showed improvement on one specific measure of a computerized maze task, but no significant benefits were observed in other cognitive tests or mood assessments. This experiment did not demonstrate lasting memory enhancements, a slowing of the aging process, or the safety profile of prolonged D-serine use in elderly individuals.

The Menin findings, while exciting, leave several critical questions open for further investigation. Researchers are still working to identify the precise triggers for Menin’s decline with age, quantify the extent to which age-related physical and cognitive deterioration can be prevented or reversed by Menin restoration, and determine the duration of any potential benefits. Furthermore, understanding whether interventions targeting Menin or D-serine could lead to unforeseen side effects remains a crucial area of inquiry.

Despite these unanswered questions, the central hypothesis remains profoundly compelling: that certain aspects of aging may be intrinsically linked to signaling pathways originating from a small, yet critical, region of the brain. Elucidating these signals could pave the way for novel strategies to preserve cognitive and physical function throughout later life. For the present, however, the evidence points towards an experimental avenue ripe for further exploration, rather than a readily available supplement proven to reverse human aging.